Tri Chemical Laboratories Inc. (TYO:4369)
3,040.00
-60.00 (-1.94%)
Sep 24, 2025, 11:30 AM JST
Tri Chemical Laboratories Balance Sheet
Financials in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jul '25 Jul 31, 2025 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 7,096 | 9,439 | 10,497 | 11,137 | 8,034 | 1,698 | Upgrade |
Cash & Short-Term Investments | 7,096 | 9,439 | 10,497 | 11,137 | 8,034 | 1,698 | Upgrade |
Cash Growth | -25.54% | -10.08% | -5.75% | 38.62% | 373.15% | 4.94% | Upgrade |
Receivables | 5,802 | 5,219 | 4,035 | 4,561 | 3,896 | 3,902 | Upgrade |
Inventory | 7,039 | 5,975 | 4,022 | 2,740 | 2,150 | 1,608 | Upgrade |
Other Current Assets | 1,197 | 823 | 454 | 484 | 306 | 376 | Upgrade |
Total Current Assets | 21,134 | 21,456 | 19,008 | 18,922 | 14,386 | 7,584 | Upgrade |
Property, Plant & Equipment | 15,378 | 10,936 | 9,269 | 8,372 | 8,014 | 7,879 | Upgrade |
Long-Term Investments | 5,159 | 4,135 | 3,186 | 4,527 | 5,624 | 4,173 | Upgrade |
Other Intangible Assets | 92 | 74 | 105 | 134 | 181 | 208 | Upgrade |
Long-Term Deferred Tax Assets | - | 342 | 295 | 158 | 82 | 22 | Upgrade |
Other Long-Term Assets | 1 | 1 | 1 | 2 | 1 | 1 | Upgrade |
Total Assets | 41,764 | 36,944 | 31,864 | 32,115 | 28,288 | 19,867 | Upgrade |
Accounts Payable | 2,447 | 969 | 354 | 1,142 | 613 | 525 | Upgrade |
Accrued Expenses | 164 | 126 | 115 | 124 | 113 | 76 | Upgrade |
Short-Term Debt | - | - | - | - | - | 580 | Upgrade |
Current Portion of Long-Term Debt | 640 | 653 | 700 | 785 | 961 | 615 | Upgrade |
Current Portion of Leases | - | 105 | 102 | 91 | 90 | 88 | Upgrade |
Current Income Taxes Payable | 1,021 | 1,295 | 235 | 787 | 800 | 593 | Upgrade |
Other Current Liabilities | 3,264 | 1,034 | 1,047 | 746 | 888 | 813 | Upgrade |
Total Current Liabilities | 7,536 | 4,182 | 2,553 | 3,675 | 3,465 | 3,290 | Upgrade |
Long-Term Debt | 402 | 722 | 1,212 | 1,913 | 2,699 | 3,160 | Upgrade |
Long-Term Leases | - | 296 | 384 | 453 | 532 | 601 | Upgrade |
Long-Term Deferred Tax Liabilities | - | - | - | 62 | 152 | 111 | Upgrade |
Other Long-Term Liabilities | 378 | 2 | 3 | 4 | 3 | 3 | Upgrade |
Total Liabilities | 8,475 | 5,357 | 4,295 | 6,240 | 6,969 | 7,267 | Upgrade |
Common Stock | 3,278 | 3,278 | 3,278 | 3,278 | 3,278 | 808 | Upgrade |
Additional Paid-In Capital | 3,179 | 3,179 | 3,179 | 3,179 | 3,179 | 709 | Upgrade |
Retained Earnings | 25,931 | 24,291 | 20,304 | 18,809 | 14,626 | 11,062 | Upgrade |
Treasury Stock | -2 | -2 | -2 | -2 | -1 | -1 | Upgrade |
Comprehensive Income & Other | 903 | 841 | 810 | 611 | 237 | 22 | Upgrade |
Shareholders' Equity | 33,289 | 31,587 | 27,569 | 25,875 | 21,319 | 12,600 | Upgrade |
Total Liabilities & Equity | 41,764 | 36,944 | 31,864 | 32,115 | 28,288 | 19,867 | Upgrade |
Total Debt | 1,042 | 1,776 | 2,398 | 3,242 | 4,282 | 5,044 | Upgrade |
Net Cash (Debt) | 6,054 | 7,663 | 8,099 | 7,895 | 3,752 | -3,346 | Upgrade |
Net Cash Growth | -22.36% | -5.38% | 2.58% | 110.42% | - | - | Upgrade |
Net Cash Per Share | 186.30 | 235.81 | 249.22 | 242.95 | 115.75 | -107.08 | Upgrade |
Filing Date Shares Outstanding | 32.5 | 32.5 | 32.5 | 32.5 | 32.5 | 31.25 | Upgrade |
Total Common Shares Outstanding | 32.5 | 32.5 | 32.5 | 32.5 | 32.5 | 31.25 | Upgrade |
Working Capital | 13,598 | 17,274 | 16,455 | 15,247 | 10,921 | 4,294 | Upgrade |
Book Value Per Share | 1024.38 | 972.00 | 848.36 | 796.23 | 656.03 | 403.24 | Upgrade |
Tangible Book Value | 33,197 | 31,513 | 27,464 | 25,741 | 21,138 | 12,392 | Upgrade |
Tangible Book Value Per Share | 1021.55 | 969.73 | 845.13 | 792.11 | 650.46 | 396.58 | Upgrade |
Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.